US Markets

Futures edge higher as investors weigh mixed signals on trade war

Credit: REUTERS/ANDREW KELLY

U.S. stock index futures recovered from overnight declines on Tuesday, pointing to a positive start for Wall Street as investors assessed conflicting comments from Washington and Beijing on their long-drawn trade dispute.

By Akanksha Rana

Aug 27 (Reuters) - U.S. stock index futures recovered from overnight declines on Tuesday, pointing to a positive start for Wall Street as investors assessed conflicting comments from Washington and Beijing on their long-drawn trade dispute.

After falling as much as 0.5% in early hours, futures tracking the S&P 500 ESCv1 pointed to a tiny 0.1% gain at the open as global stock markets took comfort from data showing China's industrial companies returned to profit in July and a rally in European stocks. MKTS/GLOB

An escalation in the U.S.-China trade tensions have battered financial markets in the recent days after both sides threatened to slap tariffs on each other's goods worth billions of dollars.

Wall Street's main indexes closed up more than 1% on Monday after U.S. President Donald Trump sought to ease tensions by predicting another round of talks with Beijing. However, China's foreign ministry reiterated on Tuesday that it had not received any recent telephone call from the United States on trade.

Investors are nervous about a deepening trade row hurting corporate profits and global growth, and the lack of clarity on the pace of U.S. interest rate cuts have only added to the woes.

With the next Federal Reserve meeting scheduled next month, investors are gauging the strength of U.S. economy for clues on where interest rates are headed. Data from the Commerce Department, due at 10:00 a.m. ET (14:00 GMT), is likely to show that consumer confidence index dropped to 129.5 in August from 135.7 in July.

At 7:24 a.m. ET, Dow e-minis 1YMcv1 were up 34 points, or 0.13%. S&P 500 e-minis EScv1 were up 4 points, or 0.14% and Nasdaq 100 e-minis NQcv1 were up 17.5 points, or 0.23%.

Among stocks, Johnson & Johnson JNJ.N rose 2% premarket after an Oklahoma judge said the drugmaker must pay $572.1 million for its part in fueling the U.S. opioid epidemic, a sum that was substantially less than investors had expected.

Other drugmakers that sell opioid painkillers and are defending against similar lawsuits were also higher. Teva Pharmaceutical Industries Ltd TEVA.N gained 4.4% while Endo International Plc ENDP.O rose 3.8%.

Shares of J. M. Smucker Co SJM.N fell 5.2% after the packaged food maker reported quarterly sales below estimates.

(Reporting by Akanksha Rana in Bengaluru; Editing by Shounak Dasgupta)

((akanksha.rana@thomsonreuters.com; within U.S. +1 646 223 8780, outside U.S. +91 80 6749 1130;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Latest Markets Videos

    Reuters

    Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

    Learn More